PURE Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards
PURE Bioscience, Inc. (PURE) had Deferred Tax Assets, Operating Loss Carryforwards of $26.84 million as of 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2025-10-29
- 2025-07-31: Deferred Tax Assets, Operating Loss Carryforwards $26.84M.
- 2024-07-31: Deferred Tax Assets, Operating Loss Carryforwards $26.84M.
- 2023-07-31: Deferred Tax Assets, Operating Loss Carryforwards $28.20M.
- 2022-07-31: Deferred Tax Assets, Operating Loss Carryforwards $27.36M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-07-31 | $26.84M 10-K · filed 2025-10-29 | |
| 2024-07-31 | $26.84M 10-K · filed 2025-10-29 | |
| 2023-07-31 | $28.20M 10-K · filed 2024-10-29 | |
| 2022-07-31 | $27.36M 10-K · filed 2023-10-30 | |
| 2021-07-31 | $26.85M 10-K · filed 2022-10-28 | |
| 2020-07-31 | $26.54M 10-K · filed 2021-10-28 | |
| 2019-07-31 | $26.94M 10-K · filed 2020-10-08 | |
| 2018-07-31 | $26.17M 10-K · filed 2019-10-30 | |
| 2017-07-31 | $30.97M 10-K · filed 2018-10-25 | |
| 2016-07-31 | $3.02M 10-K · filed 2017-10-26 | $30.16M 10-K · filed 2016-10-27 |
| 2015-07-31 | $28.20M 10-K · filed 2016-10-27 | $21.33M 10-K · filed 2015-10-28 |
| 2014-07-31 | $25.74M 10-K · filed 2015-10-28 | |
| 2013-07-31 | $22.48M 10-K · filed 2014-10-28 | |
| 2012-07-31 | $20.68M 10-K · filed 2013-10-24 | |
| 2011-07-31 | $18.33M 10-K · filed 2012-10-29 |